St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
October 29, 2025
14:00 – 15:30 CET / 8:00 a.m. – 9:30 a.m. CDT
As of 2025, 12 countries are participating in the pilot phase of the Global Platform for Access to Childhood Cancer Medicines (Global Platform). Countries around the world are taking bold steps to improve access to life-saving cancer medications for children and to advance equitable health outcomes for pediatric cancer patients in alignment with SDG 3.2 and 3.4.1 of the United Nations 17 Sustainable Development Goals, especially in low- and middle-income settings. Together, St. Jude, WHO, UNICEF, the Pan American Health Organization (PAHO), and these 12 countries are making strides towards achieving the Global Platform’s goals.
In this upcoming stakeholder engagement dialogue, we offer a unique look into the preparations made by each of the cohort member countries to achieve readiness through multi-sectoral collaboration and collective action, supported by national stakeholders and Platform partners.
Following the Fourth High-level Meeting of the UN General Assembly on the prevention and control of noncommunicable diseases and the promotion of mental health and wellbeing (HLM4), this virtual event will spotlight country experiences and explore how the Global Platform fosters country readiness through multisectoral collaboration and collective action, supported by national stakeholders and Global Platform partners. The session will focus on practical, country-driven examples of readiness, partnership and impact.
Registration is required, and interpretation services will be provided in Spanish, French, Arabic and Russian.
Dr. Carlos Rodriguez-Galindo
Executive Vice President,
Director, St. Jude Global
St. Jude Children’s Research Hospital
Ms. Dévora Kestel
Director a.i.,
Department of Noncommunicable Diseases and Mental Health (NMH)
World Health Organization